BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 21
• 22
• 23
• 24
• 27
• 28
• 29

• Genetown

  Galectin Therapeutics to Present Corporate Update at Biotechnology Industry Organization (BIO) CEO & Investor Conference

  February 9, 2012

   · 

  1 min read
• Drug Development

  Altheos, Inc. Announces Initiation of Phase 2a Clinical Trial for its Lead Glaucoma Drug Candidate, ATS907

  February 9, 2012

   · 

  1 min read
• Drug Development

  Instem Release: SNBL USA, Ltd. Moves Forward with Provantis Preclinical Solution Implementation

  February 9, 2012

   · 

  1 min read
• Business

  Sorin Group S.p.A. Release: Preliminary Results for 2011: Net Profit Increases by 48.5%

  February 9, 2012

   · 

  1 min read
• Genetown

  bluebird bio to Present at the Leerink Swann and Company 2012 Global Healthcare Conference

  February 9, 2012

   · 

  1 min read
• BioMidwest

  Zynex Expands Internationally – Forms European Subsidiary

  February 9, 2012

   · 

  1 min read
• Lone Star Bio

  Orthofix International NV Launches Centronail Ankle Compression Nailing and Lapidus Plating Systems in the U.S.

  February 9, 2012

   · 

  1 min read
• PHARNEXT Raises an Additional €8 Million for Its PleotherapyTM Platform Applied to the Treatment of Charcot-Marie Tooth Disease and Alzheimer’s Disease

  February 9, 2012

   · 

  2 min read
• Business

  Greatbatch, Inc. to Host Fourth Quarter 2011 Earnings Conference Call on February 23, 2012

  February 9, 2012

   · 

  1 min read
• Drug Development

  Protalix Biotherapeutics, Inc. Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal Disease Network Symposium

  February 9, 2012

   · 

  7 min read